Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple pill make cervical cancer screening more effective?

NCT ID NCT06669533

Recruiting now Symptom relief Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether the drug misoprostol, given before a cervical exam, can help doctors see the cervix more clearly. 420 women with a hard-to-examine cervix (called Type 3 transformation zone) will receive either misoprostol or a placebo. The goal is to see if the drug makes the cervix easier to inspect, which could lead to better detection of early signs of cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Misoprostol (a drug that softens the cervix)
What this could lead to
If it works, this could make cervical cancer screening more effective for women whose cervix is hard to see, potentially catching more pre-cancers.
What could go wrong
This is an early-stage trial focused on improving the screening process, not on curing or preventing cancer. The drug may not work better than placebo, and side effects like cramping or bleeding are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical carcinoma Uterine Cervical Neoplasms cervical cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCERS

Contacts and locations

Locations

  • Cameroon Baptist Convention Health Core, EtougEbe Baptist Hospital Yaoundé

    RECRUITING

    Yaoundé, Center Region, 2034, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.